Advanced search
Publication Cover
Pediatric Pathology & Molecular Medicine Volume 21, 2002 - Issue 5
Journal homepage
6
Views
0
CrossRef citations to date
0
Altmetric
Research Article

CLINICO-PATHOLOGIC CONFERENCE: 18-MONTH-OLD BOY WITH FEVER AND SEVERE RESPIRATORY INFECTION

William F. Pomputius Department Of Pediatrics, University of South Florida College of Medicine, Tampa, Florida, USA
,
Atilano Lacson Department of Pathology and Laboratory Medicine and Department of Pediatrics, University of South Florida College of Medicine, Tampa, Florida, USA
&
Herbert H. Pomerance Department Of Pediatrics, University of South Florida College of Medicine, Tampa, Florida, USACorrespondence[email protected]
Pages 491-506 | Published online: 09 Jul 2009

  • Green M, Michaels MG, Webber SA, Rowe D, Reyes D. The management of Epstein-Barr virus associated post-transplant lymphoproliferative disorders in pediatric solid-organ transplant recipients. PediatrTransplant. 1999;3:271-281.
  • Gross TG, Steinbuch M, DeFor T, Shapiro RS, McGlave P, Ramsay NKC, Wagner JE, Filipovich AH. B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome. Bone MarrowTransplant. 1999;23:251-258.
  • Manez R, Breinig MC, Linden P, et al. Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after transplantation: the role of cytomegalovirus disease. J Infect Dis. 1997;176:1462-1467.
  • Sigurdsson L, Reyes J, Kocoshis SA, Mazariegos G, Abu - Elmagd K, Green M. Bacteremia after intestinal transplantation in children correlates temporally with rejection or gastrointestinal lymphoproliferative disease. Transplantation. 2000, 70:302-305.
  • Sokal EM, Antunes H, Beguin C, et al. Early signs and risk factors for the increase incidence of Epstein-Barr virus-related posttransplant lymphoproliferative diseases in pediatrie liver transplant recipients treated with tacrolimus. Transplantation. 1997; 64:1438-1442.
  • Donnelly LF, Frush DP, Marshall KW, White KS. Lymphoproliferative disorders: CT findings in immunocompromised children. Am J Rad. 1998;171:725-731.
  • CollinsJ, Muller NL, Leung AN, et al. Epstein-Barr-virus-associated lymphopro-liferative disease of the lung: CTand histologie findings. Radiology. 1998;208:749-759.
  • Chadburn A, Cesarman E, Knowles DM. Molecular pathology of posttransplantation lymphoproliferative disorders. Semin Diagn Pathol. 1997;14:15-26.
  • Mosier DE. Epstein-Barr virus and lymphoproliferative disease. Curr Opin Hematol. 1999;6:25-29.
  • Swinnen LJ. Overview of posttransplant B-cell lymphoproliferative disorders. Semin OncoL 1999;26(suppl 14):21-25.
  • Harmon WE, Dharnidharka VK. Lymphoproliferative disease in children. Transplant Proc. 1999;31:1268-1269.
  • Lucas KG, Small TN, Heller G, Dupont B, O"Reilly RJ. The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation. Blood. 1996;87:2594-2603.
  • Gonthier DM, Hartman G, HolleyJL. Posttransplant lymphoproliferative disorder presenting as an isolated skin lesion. Am J Kidney Dis. 1992;19:600-603.
  • McGregorJM, Yu CCW, Lu QL, Cotter FE, Levison DA, Macdonald DM. Posttransplant cutaneous lymphoma. JAm Acad Dermatol. 1993;29:549-554.
  • Iwatsuki K, Zigang X, Ohtsuka M, Kaneko F. Cutaneous lymphoproliferative disorders associated with Epstein-Barr virus infection: a clinical overview. JDermatol Sci. 2000,22:181-195.
  • Green M. Personal communication, 2000.
  • Iwatsuki K, Ohtsuka M, Harada H, Han G, Kaneko F. Clinicopathologic manifestations of Epstein-Barr virus-associated cutaneous lymphoproliferative disorders. Arch Dermatol. 1997;133:1081-1086.
  • Chai C, White WL, Shea CK, Prieto VG. Epstein-Barr virus-associated lymphoproliferative disorders primarily involving the skin. J Cutan Pathol. 1999;26:242-247.
  • Darenkov IA, Marcarelli MA, Basadonna GP, et al. Reduced incidence of EpsteinBarr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy. Transplantation. 1997;64:848-852.
  • Nadal D, GuzmanJ, Frohlich S, Braun DG. Human immunoglobulin preparations suppress the occurrence of Epstein-Barr virus-associated lymphoproliferation. Exp Hematol. 1997;25:223-231.
  • Green M, Cacciarelli TV, Mazariegos GV, et al. Serial measurement of EpsteinBarr viral load in peripheral blood in pediatrie liver transplant recipients during treatment for posttransplant lymphoproliferative disease. Transplantation. 1998;66:1641-1644.
  • Kuehnle I, Huis MH, Zhensheng L, et al. CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation. Blood. 2000,95:1502-1505.
  • Heslop HE, Rooney CM. Adoptive cellular immunotherapy for EBV lymphoproliferative diseases. Immunol Rev. 1997;157:217-222.
  • Nalesnik MA, Rao AS, Furukawa H, et al. Autologous lymphokine-activated killer cell therapy of Epstein-Barr virus-positive and -negative lymphoproliferative disorders arising in organ transplant recipients. Transplantation. 1998;63:1200-1205.
  • Lucas KG, Burton RL, Zimmerman SE, et al. Semiquantitative Epstein-Barr virus (EBV) polymerase chain reaction for the determination of patients at risk for EBV-induced lymphoproliferative disease after stem cell transplantation. Blood. 1998;91:3654-3661.
  • Reed JC. 1997. Chest Radiology: Plain Film Patterns and Differential Diagnoses, ed. 3. St. Louis: Mosby; 1997.
  • Worthy SA, Flint JD, Muller NL. Pulmonary complications after bone marrow transplantation: high-resolution CT and pathologic findings. Radiographies. 1997; 17:1359-1371.
  • van Burik J-A, Weisdorf DJ. Infections in recipients of blood and marrow transplantation. Hematol Oncol Clin North Am. 1999;13:1065-1089.
  • Paessler M, Kossev P, Raghunath P, et al. SHP-I expression correlates with postgerminal center cell derivation of post-transplant lymphoproliferative disorders. Annual Meeting Abstract #1029. Mod Pathol. 2001;14:175a.
  • Curtis RE, Travis LB, Rowlings PA, et al. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood. 1999;94:2208-2216.
  • Muti G, De Gasperi A, Cantoni S, et al. Incidence and clinical characteristics of posttransplant lymphoproliferative disorders: report from a single center. Transplant Int.2000;13(Suppl 1):S382-S387.
  • Geis MC, Graczyk MJ, ManivelJC, CoadJE. Post-transplant lymphoma (PTLD): variations by transplant type (TX). Annual Meeting Abstract #959. ModPathol. 2001;14:164a.
  • Lines MA, Lopez-Pteriidae D, Shiitake IP, RosenthalJ, Said JW. Posttransplant lymphoproliferative disorder in pediatrie bone marrow transplant recipients: disseminated disease of donor origin demonstrated by fluorescence in situ hybridization. Arch Pathol Lab Med. 1998; 122:708-714.
  • Dror Y, Greenberg M, Taylor G, et al. Lymphoproliferative disorders after organ transplantation in children. Transplantation. 1999;67:990-998.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.